EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

A natural experiment in Kenya reveals durable immunosuppressive effects of early childhood malaria: a longitudinal cohort study

Mercy S Safari iD, Timothy O Makori, Elijah T Gicheru, Maureen W Mburu, Omar K Nyawa, Faiz M Shee, James Nyagwange, Eunice W Kagucia, Francis Maina Ndungu iD, Timothy Chege Kuria, James O Tuju, Charles J Sande iD

eLife · 2026

DOI: 10.7554/elife.107820 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift eLife, 2026. Verfasst von Mercy S Safari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. Hauptthemen laut MEDLINE: Malaria, Falciparum, Plasmodium falciparum, Immune Tolerance. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Wellcome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic malaria exposure has been proposed to modulate immune function, but its long-term effects on antibody-mediated responses to unrelated pathogens remain poorly defined. Whether these effects persist beyond periods of active infection and how early-life exposure shapes humoral immunity over time is not well understood.

Methods

We leveraged a natural experiment in coastal Kenya – where two regions (Junju and Ngerenya) diverged sharply in malaria transmission from around 2004 – to evaluate the long-term immunological consequences of malaria exposure in childhood. Using a protein microarray platform, we measured IgG responses to vaccine and pathogen antigens in 123 children sampled longitudinally over a 15-year period. Active weekly malaria surveillance enabled precise reconstruction of individual exposure histories.

Results

IgG responses to Plasmodium falciparum apical membrane antigen 1 (AMA1) tracked closely with clinical malaria episodes, confirming the ability of the microarray platform to detect biologically meaningful variation in antigen-specific immunity. Despite comparable vaccination histories, children from the high malaria transmission setting (Junju) exhibited persistently lower measles-specific IgG levels than children from the low-transmission setting (Ngerenya), a pattern validated by ELISA. In longitudinal analyses, children from Junju exhibited lower antibody responses to a range of unrelated antigens, including Bordetella pertussis , CMV, rubella, and measles, with similar differences evident in cross-sectional analyses at 10 years of age. Within the Ngerenya cohort, children with documented early-life malaria had broadly lower IgG responses at age 10 compared to malaria-naive peers, despite identical geography, vaccines, and follow-up duration.

Conclusions

These findings suggest that malaria exposure during early childhood is linked with durable suppression of antibody responses to unrelated pathogens and vaccines. This effect persists long after infection and may partially explain the overall diminished long-term vaccine effectiveness in malaria-endemic settings. Funding: This study was supported by fellowship funding to C.J.S. from the Wellcome Trust (WT105882MA). The funder played no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript. M.S.S was funded in whole by Science for Africa Foundation to the Developing Excellence in Leadership, Training, and Science in Africa (DELTAS Africa) program [DEL-22–012] with support from Wellcome Trust and the UK Foreign, Commonwealth & Development Office and is part of the EDCPT2 programme supported by the European Union. For purposes of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, FalciparumPlasmodium falciparumImmune ToleranceHumansKenyaLongitudinal StudiesImmunoglobulin GAntigens, ProtozoanAntibodies, ProtozoanChild, PreschoolInfantFemaleMaleProtozoan ProteinsMembrane ProteinsChildMalaria Vaccines

Stichwörter der Autor:innen

P. falciparumantibodyepidemiologyglobal healthimmunosupressionmalarianatural experiment

Substanzen

Immunoglobulin GAntigens, ProtozoanAntibodies, ProtozoanProtozoan Proteinsapical membrane antigen I, PlasmodiumMembrane ProteinsMalaria Vaccines

Autor:innen und Institutionen

  • Bioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Pwani University, Kilifi, Kenya.
  • Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.
  • Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, United States.
  • Kenya Medical Research Institute, Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.

ORCID-Profile: Mercy S Safari, Francis Maina Ndungu, Charles J Sande

Förderung

  • Wellcome Trust
  • Wellcome

Zitieren

APA

Safari, M. S., Makori, T. O., Gicheru, E. T., Mburu, M. W., Nyawa, O. K., Shee, F. M., Nyagwange, J., Kagucia, E. W., Ndungu, F. M., Kuria, T. C., Tuju, J. O., & Sande, C. J. (2026). A natural experiment in Kenya reveals durable immunosuppressive effects of early childhood malaria: a longitudinal cohort study. eLife. https://doi.org/10.7554/elife.107820

Vancouver

Safari MS, Makori TO, Gicheru ET, Mburu MW, Nyawa OK, Shee FM, et al. A natural experiment in Kenya reveals durable immunosuppressive effects of early childhood malaria: a longitudinal cohort study. eLife. 2026. doi:10.7554/elife.107820

BibTeX
@article{Safari2026,
  author = {Safari, Mercy S and Makori, Timothy O and Gicheru, Elijah T and Mburu, Maureen W and Nyawa, Omar K and Shee, Faiz M and Nyagwange, James and Kagucia, Eunice W and Ndungu, Francis Maina and Kuria, Timothy Chege and Tuju, James O and Sande, Charles J},
  title = {A natural experiment in Kenya reveals durable immunosuppressive effects of early childhood malaria: a longitudinal cohort study},
  journal = {eLife},
  year = {2026},
  doi = {10.7554/elife.107820}
}
Kostenlos starten →